Unicorns may be mythical beasts, but multibillion-dollar start-ups are alive and well and running wild on Wall Street. Design ...

Shares of Vertex Pharmaceuticals Inc. VRTX rose 1.15% to $462.13 Friday, on what proved to be an all-around grim trading ...

Buying $1000 In VRTX: If an investor had bought $1000 of VRTX stock 15 years ago, it would be worth $12,638.75 today based on a price of $457.22 for VRTX at the time of writing.

It’s not often that a CEO outright dismisses M&A prospects, but Moderna CEO Stéphane Bancel says the mRNA biotech has enough ...

Now, it’s worth noting Stock Advisor's total average return is 1,049% — a market-crushing outperformance compared to 182% for the S&P 500. Don’t miss out on the latest top 10 list, available when you ...

Some Boston public school students are spending their summer vacations learning and working at a global biotech company.

Frazier was among the most active venture investors in 2024, according to analysts at William Blair, backing 17 private life ...

Vertex Pharmaceuticals (VRTX) wrapped up July with a modest 0.16% uptick, signaling a cautious optimism in the stock market.

U.S. equities rebounded strongly in Q2, with growth stocks and mid-caps leading gains; our portfolio outperformed via IT, ...

Franklin Templeton shares Q2 2025 results for ClearBridge All Cap Growth Portfolios: tech wins offset health care drag. See ...

Vertex Pharmaceuticals is making waves, popping up as one of the most searched stocks. Should you jump on the bandwagon?

AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, TD Cowen analyst Steve Scala said.